Is Lasa Supergenerics Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Lasa Supergenerics Ltd (LASA.NS) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Lasa Supergenerics Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Lasa Supergenerics Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Lasa Supergenerics Ltd?

Muslim investors may consider investing in Lasa Supergenerics Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Lasa Supergenerics Ltd classified as HALAL?

Musaffa determines the Shariah status of Lasa Supergenerics Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Lasa Supergenerics Ltd updated?

The Shariah compliance status of Lasa Supergenerics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Lasa Supergenerics Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Lasa Supergenerics Ltd?

You can check the latest Shariah compliance status of Lasa Supergenerics Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

LASA.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: January 27, 2026

Report Source: 2026 2nd Quarter Report

Lasa Supergenerics Ltd. Stock Analysis LASA.NS

India Health Care Nano Cap Report: Q2, 2026

Lasa Supergenerics Ltd. engages in the manufacture of veterinary preparations. The firm is engaged in the business of manufacturing, trading, producing, processing, preparing, and treating chemicals, API, pharmaceuticals, drugs, and others. The company specializes in catalyst chemistry and manufactures anthelmintic/ veterinary API products with production capabilities and product categories in India. The firm's products include API products, other API products, animal feed ingredients and reagents for therapeutic use. Its API products include Fenbendazole, Toldimphos sodium, Cyromazine, Albendazole, Riclabendazole, Rafoxanide, Ornidazole, 2,6-Diiodo-4-Nitrophenol, Ricobendazole, Oxfendazole, Closantel Base, Closantel sodium, Nitroxynil, Halquinol, and Oxyclozanide. The firm's manufacturing facility is located in Chiplun, Maharashtra.

Key Statistics of Lasa Supergenerics Ltd (LASA.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹7.73₹8.15

Today's Open

₹7.73

Volume

6922.00

P/E Ratio (TTM)

52 Week Range

₹5.67₹19.00

Market Cap

408.83M

Avg. Volume

21.37K

Dividend Yield

Financial Metrics & Statements of Lasa Supergenerics Ltd (LASA.NS)

FAQ's for Lasa Supergenerics Ltd (LASA.NS)

According to Musaffa’s Shariah screening methodology, Lasa Supergenerics Ltd (LASA.NS) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.